Literature DB >> 23143365

Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.

Theresa Judge1, Jason M Pogue, Dror Marchaim, Kevin Ho, Srinivasa Kamatam, Shakila Parveen, Namita Tiwari, Priyanka Nanjireddy, Suchitha Bheemreddy, Caitlin Biedron, Sagar Mallikethi Lepakshi Reddy, Vijaykumar Khammam, Indu K Chalana, Rajachendra Shekher Tumma, Vicki Collins, Adnan Yousuf, Paul R Lephart, Emily T Martin, Michael J Rybak, Keith S Kaye, Kayoko Hayakawa.   

Abstract

A retrospective case-case control study was conducted, including 60 cases with daptomycin-nonsusceptible vancomycin-resistant enterococci (DNS-VRE) matched to cases with daptomycin-susceptible VRE and to uninfected controls (1∶1∶3 ratio). Immunosuppression, presence of comorbid conditions, and prior exposure to antimicrobials were independent predictors of DNS-VRE, although prior daptomycin exposure occurred rarely. In summary, a case-case control study identified independent risk factors for the isolation of DNS-VRE: immunosuppression, multiple comorbid conditions, and prior exposures to cephalosporines and metronidazole.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23143365     DOI： 10.1086/668438

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  9 in total

1.  Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.

Authors:  Adam J DiPippo; Frank P Tverdek; Jeffrey J Tarrand; Jose M Munita; Truc T Tran; Cesar A Arias; Samuel A Shelburne; Samuel L Aitken
Journal:  J Infect       Date:  2016-11-11       Impact factor: 6.072

2.  Characterization of daptomycin non-susceptible Enterococcus faecium producing urinary tract infection in a renal transplant recipient.

Authors:  Antonio Sorlózano; Diana Panesso; José María Navarro-Marí; Cesar A Arias; José Gutiérrez-Fernández
Journal:  Rev Esp Quimioter       Date:  2015-08       Impact factor: 1.553

3.  Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.

Authors:  Evan J Zasowski; Kimberly C Claeys; Abdalhamid M Lagnf; Susan L Davis; Michael J Rybak
Journal:  Clin Infect Dis       Date:  2016-03-03       Impact factor: 9.079

4.  Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility.

Authors:  Guiqing Wang; Sitharthan Kamalakaran; Abhay Dhand; Weihua Huang; Caroline Ojaimi; Jian Zhuge; Leslie Lee Yee; Pramod Mayigowda; Pavan Kumar Makam Surendraiah; Nevenka Dimitrova; John T Fallon
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

5.  Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream Infections.

Authors:  Robert J Woods; Twisha S Patel; Jerod L Nagel; Duane W Newton; Andrew F Read
Journal:  Infect Control Hosp Epidemiol       Date:  2018-01-14       Impact factor: 3.254

6.  Vancomycin-resistant enterococci with reduced daptomycin susceptibility in Singapore: prevalence and associated factors.

Authors:  A Chow; N N Win; P Y Ng; W Lee; M K Win
Journal:  Epidemiol Infect       Date:  2016-05-13       Impact factor: 4.434

7.  Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid-Nonsusceptible Vancomycin-Resistant Enterococcus.

Authors:  Matthew H Greene; Bryan D Harris; Whitney J Nesbitt; Marley L Watson; Patty W Wright; Thomas R Talbot; George E Nelson
Journal:  Open Forum Infect Dis       Date:  2018-10-09       Impact factor: 3.835

8.  An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogen.

Authors:  Valerie J Morley; Clare L Kinnear; Derek G Sim; Samantha N Olson; Lindsey M Jackson; Elsa Hansen; Grace A Usher; Scott A Showalter; Manjunath P Pai; Robert J Woods; Andrew F Read
Journal:  Elife       Date:  2020-12-01       Impact factor: 8.140

9.  Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy.

Authors:  Takashi Matono; Kayoko Hayakawa; Risen Hirai; Akira Tanimura; Kei Yamamoto; Yoshihiro Fujiya; Momoko Mawatari; Satoshi Kutsuna; Nozomi Takeshita; Kazuhisa Mezaki; Norio Ohmagari; Tohru Miyoshi-Akiyama
Journal:  BMC Res Notes       Date:  2016-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.